Results
Goldline Pharma H1 Net Profit Rises 44.5% YoY
Board approved unaudited standalone financial results with revenue of ₹14.93 crore and net profit of ₹2.05 crore for H1 FY2026.
Share capital increased to ₹11.41 crore from ₹8.71 crore, indicating a c
